Timothy P. Lynch’s Stonepine Capital Portfolio: Top 5 Healthcare Stocks

Page 5 of 5

1. Amryt Pharma plc (NASDAQ:AMYT)

Stonepine Capital’s Stake Value: $69,882,000

Percentage of Stonepine Capital’s 13F Portfolio: 31.79%

Number of Hedge Fund Holders: 18

Amryt Pharma plc (NASDAQ:AMYT), a biopharmaceutical company targeting rare and debilitating diseases with its multitude of existing and developing treatments, is the largest holding in Stonepine Capital’s Q3 portfolio. Timothy Lynch, via Stonepine Capital, holds 5.8 million Amryt Pharma plc (NASDAQ:AMYT) shares, worth almost $70 million, representing 31.79% of the firm’s portfolio of Q3 securities. 

Glenn Russell Dubin’s Highbridge Capital Management is one of the leading stakeholders of Amryt Pharma plc (NASDAQ:AMYT), holding a $19.75 million stake in the company. Overall, 18 hedge funds in the database of Insider Monkey were long Amryt Pharma plc (NASDAQ:AMYT) as of Q3 2021, up from 11 funds in the preceding quarter. 

You can also take a look at 11 Best Autonomous Vehicle Stocks To Buy Now and Cathie Wood Stock Portfolio: 10 Newest Stock Picks This Year

Page 5 of 5